enoximone has been researched along with Coronary Heart Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 19 (86.36) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazmaier, S; Sonntag, H; Stephan, H | 1 |
| Barbato, G; Bracchetti, D; Cantelli, I; Casella, G; Pavesi, PC | 1 |
| Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B | 1 |
| Schlepper, M | 1 |
| Mitrovic, V; Neuzner, J; Opper, H; Schlepper, M; Thormann, J | 1 |
| Döring, B; el-Banayosy, A; Hartmann, D; Körfer, R; Körner, MM; Körtke, H; Posival, H | 1 |
| Brezina, A; Kakác, J; Pirk, J | 1 |
| Cocca-Spofford, D; Dec, GW; Fifer, MA; Herrmann, HC; Semigran, MJ | 1 |
| Dütschke, P; Petry, A; Regensburger, D | 1 |
| Berwing, K; Mitrovic, V; Schlepper, M; Strasser, R; Thormann, J | 1 |
| Thormann, J | 1 |
| World, MJ | 1 |
| Bahavar, H; Dieterich, HA; Mitrovic, V; Neuzner, J; Petrovic, O; Schlepper, M | 1 |
| Friedel, N; Hetzer, R; Lemme, A; Schüler, S; Teebken, M | 1 |
| Zeplin, HE | 1 |
| Peters, P; Saborowski, F; Schneider, M | 1 |
| Boldt, J; Dieterich, HA; Hempelmann, G; Kling, D; Marck, P | 1 |
| Dieterich, HA; Hueting, J; Kremer, P; Mitrovic, V; Schlepper, M; Thormann, J; Wissemann, J | 1 |
| Boldt, J; Hempelmann, G; Kling, D; Moosdorf, R | 1 |
| Mitrovic, V; Schlepper, M; Thormann, J | 1 |
| Bahawar, H; Dieterich, HA; Mitrovic, V; Neuzner, J; Schlepper, M; Thormann, J; Volz, M | 1 |
| Bahavar, H; Dieterich, HA; Mitrovic, V; Neuzner, J; Schlepper, M; Volz, M | 1 |
1 review(s) available for enoximone and Coronary Heart Disease
| Article | Year |
|---|---|
Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors.
Topics: Animals; Colforsin; Coronary Disease; Enoximone; Hemodynamics; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1989 |
8 trial(s) available for enoximone and Coronary Heart Disease
| Article | Year |
|---|---|
[Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
Topics: Adult; Aged; Anesthesia; Blood Pressure; Coronary Disease; Enoximone; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Quinazolines; Stroke Volume; Vascular Resistance | 1995 |
Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Cross-Over Studies; Digoxin; Enoximone; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Ventricular Function, Left | 1994 |
[The anti-ischemic effect of phosphodiesterase III inhibitors].
Topics: Administration, Oral; Calcium; Coronary Circulation; Coronary Disease; Cyclic AMP; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Enoximone; Exercise Test; Gallopamil; Hemodynamics; Humans; Infusions, Intravenous; Myocardial Contraction; Myocardial Ischemia | 1994 |
Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Coronary Disease; Electrocardiography; Enoximone; Female; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
[The effect of enoximone and catecholamines on renal function after open heart surgery].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Diuresis; Dobutamine; Enoximone; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Imidazoles; Kidney Function Tests; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Prospective Studies; Vascular Resistance | 1991 |
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
The new phosphodiesterase inhibitor enoximone in patients following cardiac surgery--pharmacokinetics and influence on parameters of coagulation.
Topics: Aged; Blood Coagulation; Coronary Artery Bypass; Coronary Disease; Enoximone; Humans; Imidazoles; Middle Aged; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Stroke Volume | 1990 |
Enoximone treatment of impaired myocardial function during cardiac surgery: combined effects with epinephrine.
Topics: Aged; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Enoximone; Epinephrine; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Intraoperative Period; Middle Aged; Time Factors | 1990 |
13 other study(ies) available for enoximone and Coronary Heart Disease
| Article | Year |
|---|---|
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
Topics: Aged; Cardiac Output, Low; Cohort Studies; Coronary Disease; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Vasodilation | 1994 |
[Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Coronary Disease; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1994 |
[New avenues in therapy of postoperative low output syndrome].
Topics: Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Critical Care; Dopamine; Drug Therapy, Combination; Enoximone; Epinephrine; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Postoperative Complications; Reoperation; Resuscitation; Survival Rate | 1994 |
[Hemodynamic effects of enoximone in patients with low left ventricular ejection fraction in surgery for ischemic heart disease].
Topics: Adult; Aged; Cardiac Output, Low; Coronary Disease; Enoximone; Hemodynamics; Humans; Middle Aged; Postoperative Complications; Risk Factors; Stroke Volume | 1993 |
Long-term outcome of enoximone therapy in patients with refractory heart failure.
Topics: Cardiomyopathy, Dilated; Cause of Death; Coronary Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 1993 |
Effects of enoximone on right-ventricular function in patients with impaired myocardial performance.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Disease; Enoximone; Hemodynamics; Humans; Middle Aged; Myocardial Revascularization; Phosphodiesterase Inhibitors; Stroke Volume; Thermodilution; Ventricular Dysfunction, Right; Ventricular Function, Right | 1996 |
[Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].
Topics: Adult; Aged; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Diastole; Echocardiography, Doppler; Electrocardiography; Enoximone; Female; Hemodynamics; Humans; Infusion Pumps; Male; Middle Aged; Myocardial Contraction; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1996 |
The influence of clinical intervention on pressure-volume relationships--the conductance (volume) technique.
Topics: Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Computer Graphics; Coronary Angiography; Coronary Disease; Enoximone; Heart Failure; Humans; Imidazoles; Myocardial Contraction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Stroke Volume; Ventricular Function, Left | 1992 |
Patterns of response to intravenous enoximone.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Monitoring, Physiologic | 1991 |
[Enoximone as pharmacologic "bridging" to heart transplantation].
Topics: Adolescent; Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Combined Modality Therapy; Coronary Disease; Enoximone; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Prognosis | 1991 |
Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique.
Topics: Aged; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Enoximone; Female; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Stroke Volume; Vena Cava, Inferior; Ventricular Function, Left | 1990 |
Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.
Topics: Atrial Natriuretic Factor; Catecholamines; Coronary Circulation; Coronary Disease; Enoximone; Hemodynamics; Humans; Imidazoles; Lactates; Lactic Acid; Middle Aged; Neurotransmitter Agents; Phosphodiesterase Inhibitors; Prostaglandins | 1989 |
[Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
Topics: Aged; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Electrocardiography; Energy Metabolism; Enoximone; Epinephrine; Exercise Test; Female; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine | 1988 |